Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Movva

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 4, 2015
Mitral Annular Dynamics in Mitral Annular Calcification: A Three-Dimensional Imaging StudyGregg S Pressman, Rajesh Movva, Yan Topilsky, et al.
Clinical and Translational Science|August 11, 2017
Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled TrialRichard L Dunbar, Rajesh Movva, LeAnne T Bloedon, et al.
Journal of Lipid Research|March 8, 2008
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patientsLeanne T Bloedon, Richard Dunbar, Danielle Duffy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 8, 2008
Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndromeJohn S Millar, Danielle Duffy, Ramprasad Gadi, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 4, 2015
Mitral Annular Dynamics in Mitral Annular Calcification: A Three-Dimensional Imaging StudyGregg S Pressman, Rajesh Movva, Yan Topilsky, et al.
Clinical and Translational Science|August 11, 2017
Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled TrialRichard L Dunbar, Rajesh Movva, LeAnne T Bloedon, et al.
Journal of Lipid Research|March 8, 2008
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patientsLeanne T Bloedon, Richard Dunbar, Danielle Duffy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 8, 2008
Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndromeJohn S Millar, Danielle Duffy, Ramprasad Gadi, et al.
Pageof 2